| 1. |  3PBIOVIAN Noáin (Navarra), Spain | CDMO | Commercial | VIEW |
| 2. |  3PBIOVIAN Turku, Finland (Biovian) / Pamplona, Spain (3P) - now pan-European | CDMO | CDMO - supports clients' pipelines from Discovery through Commercial | VIEW |
| 3. |  5QBD-Biotech Aydat, France | CRO | Service Provider | VIEW |
| 4. |  Aardvark Therapeutics San Diego, USA | Biotech | Phase 3 | VIEW |
| 5. |  Abcuro, Inc. Newton, Massachusetts, USA | Biotech | Phase 2/3 | VIEW |
| 6. |  Acadia Pharmaceuticals Inc. San Diego, USA | Biotech | Commercial | VIEW |
| 7. |  Actaros London, United Kingdom | CRO | Commercial | VIEW |
| 8. |  Advanced Clinical Deerfield, Illinois, USA | CRO | Commercial | VIEW |
| 9. |  Advanz Pharma London, United Kingdom | Biotech | Commercial|Phase 2|Phase 3 | VIEW |
| 10. |  Agios Pharmaceuticals Cambridge, USA | Biotech | Commercial | VIEW |
| 11. |  Agomab Therapeutics Antwerp, Belgium | Biotech | Phase 2 | VIEW |
| 12. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 13. |  Aico Worldwide Boston, USA | Digital Health | Commercial | VIEW |
| 14. |  Ajou University Suwon, South Korea | Biotech | Phase 3 | VIEW |
| 15. |  Akebia Therapeutics Cambridge, USA | Biotech | Commercial | VIEW |
| 16. |  Akkodis Zurich, Switzerland | CRO | Commercial | VIEW |
| 17. |  | CDMO | Commercial | VIEW |
| 18. |  Alkeus Pharmaceuticals Cambridge, USA | Biotech | Phase 3 | VIEW |
| 19. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 20. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 21. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 22. |  Amgen Thousand Oaks, California, United States | Pharma | Discovery through Commercial | VIEW |
| 23. |  Amplity Health Langhorne, PA, USA | CRO | - | VIEW |
| 24. |  Apellis Pharmaceuticals, Inc. Waltham, Massachusetts, USA | Biotech | Commercial | VIEW |
| 25. |  Apothecon Pharmaceuticals Pvt. Ltd. Vadodara, India | CDMO | Commercial | VIEW |
| 26. |  | CDMO | Commercial | VIEW |
| 27. |  Argo Biopharma Shanghai, China | Biotech | Phase 2 | VIEW |
| 28. |  | CRO | Commercial | VIEW |
| 29. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 30. |  AstraZeneca Cambridge, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 31. |  AutoCruitment Atlanta, Georgia, USA | CRO | Commercial | VIEW |
| 32. |  Autolus Therapeutics London, United Kingdom | Biotech | Commercial + Phase 1/2 | VIEW |
| 33. |  BC Platforms Zurich, Switzerland | Digital Health | Commercial | VIEW |
| 34. |  BIAL São Mamede do Coronado, Trofa, Porto, Portugal | Biotech | Phase 2 (lead candidate) | VIEW |
| 35. |  | Biotech | Discovery | VIEW |
| 36. |  BRIM Biotechnology, Inc. Taipei, Taiwan | Biotech | Phase 3 | VIEW |
| 37. |  | Pharma | Discovery through Commercial | VIEW |
| 38. |  Belief BioMed Shanghai, China | Biotech | Commercial | VIEW |
| 39. |  Berg Health Framingham, Massachusetts, USA | Biotech | Phase 1/2 | VIEW |
| 40. |  BioLineRx Ltd. Modiin, Israel | Biotech | Commercial | VIEW |
| 41. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 42. |  BioNTech SE Mainz, Germany | Biotech | Commercial | VIEW |
| 43. |  Bioclinica Princeton, New Jersey, USA | CRO | Commercial | VIEW |
| 44. |  Biotech Advisory Lab Basel, Switzerland | CRO | Commercial | VIEW |
| 45. |  Blueprint Medicines Cambridge, USA | Biotech | Commercial | VIEW |
| 46. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 47. |  Boston Institute of Biotechnology Southborough, USA | CDMO | Commercial | VIEW |
| 48. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 49. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 50. |  CEVA Logistics Marseille, France | CRO | Commercial | VIEW |
| 51. |  CMC Pharmaceuticals Solon, Ohio, USA | CDMO | Commercial | VIEW |
| 52. |  CS Pharmaceuticals Limited London, United Kingdom | Biotech | Phase 2 | VIEW |
| 53. |  | Digital Health | Commercial | VIEW |
| 54. |  CURE5 Foundation New York, USA | Biotech | Discovery | VIEW |
| 55. |  | Biotech | Commercial | VIEW |
| 56. |  Carbogen Amcis Bubendorf, Switzerland | CDMO | Commercial | VIEW |
| 57. |  Care Access Boston, Massachusetts | CRO | Commercial | VIEW |
| 58. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 59. |  Carroll Bio-Consulting Boston, USA | Biotech | Commercial | VIEW |
| 60. |  Catalent, Inc. Tampa, Florida, USA | CDMO | Commercial | VIEW |
| 61. |  Cellares South San Francisco, USA | CDMO | Commercial | VIEW |
| 62. |  Cencora Conshohocken, Pennsylvania, United States | Pharma | Commercial (as distributor/logistics provider) | VIEW |
| 63. |  Cencora Conshohocken, Pennsylvania, USA | Pharma | Commercial | VIEW |
| 64. |  Center for Neuromusculoskeletal Restorative Medicine Limited Shatin, Hong Kong | Biotech | Preclinical | VIEW |
| 65. |  Centogene Rostock, Germany | Diagnostics | Preclinical | VIEW |
| 66. |  Cerbios-Pharma SA Barbengo-Lugano, Switzerland | CDMO | Preclinical|Clinical|Commercial | VIEW |
| 67. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 68. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 69. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 70. |  China Resources Double-Crane Pharmaceutical Co., Ltd. Beijing, China | Pharma | Commercial | VIEW |
| 71. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | Pharma | Commercial | VIEW |
| 72. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 73. |  Chugai Pharmaceutical Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 74. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 75. |  City of Hope Duarte, California, USA | Biotech | Commercial | VIEW |
| 76. |  Claire Davies Pharma Consulting Limited Deal, United Kingdom | CRO | Commercial | VIEW |
| 77. |  ClearView Healthcare Partners Newton, USA | CRO | - | VIEW |
| 78. |  Clinical Process Services (CPS) Dubai, United Arab Emirates | CRO | Commercial | VIEW |
| 79. |  Clinical Service Center (CSC) Suzhou, China | CRO | Commercial | VIEW |
| 80. |  Clinical2Digital San Diego, USA | Digital Health | Commercial | VIEW |
| 81. |  Codexis, Inc. Redwood City, California, USA | Biotech | Commercial | VIEW |
| 82. |  Conexus Solutions, Inc. Branchburg, USA | Digital Health | Commercial | VIEW |
| 83. |  Coral Healthcare Beijing, China | Digital Health | Commercial | VIEW |
| 84. |  Covance Princeton, New Jersey, USA | CRO | N/A - Service provider, not drug developer | VIEW |
| 85. |  Cupperson London, United Kingdom | CRO | Self-funded | VIEW |
| 86. |  Curatis Liestal, Switzerland | Biotech | Phase 3 | VIEW |
| 87. |  | Biotech | Phase 2 | VIEW |
| 88. |  Curebase San Francisco, USA | Digital Health | Commercial | VIEW |
| 89. |  Curestack Tampa, Florida, USA | Digital Health | Commercial | VIEW |
| 90. |  Cuttsy+Cuttsy Cambridge, United Kingdom | CRO | N/A (Service Provider) | VIEW |
| 91. |  Cyborg Advisor New York, USA | Digital Health | Commercial | VIEW |
| 92. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 93. |  | CRO | Service Provider | VIEW |
| 94. |  Cytiva Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 95. |  Cytochroma Edinburgh, United Kingdom | Biotech | Discovery | VIEW |
| 96. |  Cytocom, Inc. Fort Collins, Colorado, USA | Biotech | Phase 2/Phase 3 | VIEW |
| 97. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 98. |  Cytovance Biologics Oklahoma City, USA | CDMO | Commercial | VIEW |
| 99. |  | Biotech | Phase I/II - Phase II | VIEW |
| 100. |  Daicel Chiral Technologies Hyderabad, India (Regional HQ); West Chester, PA, USA (Global HQ) | CDMO | Commercial | VIEW |
| 101. |  Dankook University Yongin and Cheonan, South Korea | Biotech | Phase 2 | VIEW |
| 102. |  Dartmouth College Hanover, USA | Biotech | Phase 3 | VIEW |
| 103. |  Day One Biopharmaceuticals Brisbane, United States | Biotech | Commercial | VIEW |
| 104. |  Debiopharm Lausanne, Switzerland | Biotech | Phase 1, Phase 2, Phase 3 | VIEW |
| 105. |  Definitive Healthcare Framingham, USA | Digital Health | Commercial | VIEW |
| 106. |  Deloitte France Puteaux (Paris La Défense), France | CRO | Commercial | VIEW |
| 107. |  Delve-RW LLC Franklin, Massachusetts, USA | CRO | Commercial | VIEW |
| 108. |  Dompé Farmaceutici Milan, Italy | Biotech | Commercial | VIEW |
| 109. |  Drug & Biotechnology Development, LLC Clearwater, USA | CRO | Commercial | VIEW |
| 110. |  | CRO | Commercial | VIEW |
| 111. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 112. |  ENCell Co., Ltd. Seoul, South Korea | CDMO | Phase 2 | VIEW |
| 113. |  ENGEDI RX Roswell, Georgia, USA | CRO | Commercial | VIEW |
| 114. |  ETH Zürich Zurich, Switzerland | Biotech | Discovery | VIEW |
| 115. |  EVERSANA Chicago, Illinois, USA | CRO | Commercial | VIEW |
| 116. |  EY Global Delivery Services (GDS) London, United Kingdom | CRO | Late Stage | VIEW |
| 117. |  Ecolab Inc. Saint Paul, USA | Pharma | Commercial | VIEW |
| 118. |  Elevance Health Indianapolis, USA | Digital Health | Commercial | VIEW |
| 119. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 120. |  Emblem AI San Francisco, USA | Digital Health | Commercial | VIEW |
| 121. |  | Biotech | Clinical | VIEW |
| 122. |  | Biotech | Preclinical | VIEW |
| 123. |  Escientia Life Sciences South Windsor, Connecticut, USA | CDMO | Commercial | VIEW |
| 124. |  Escientia Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 125. |  Esteve Healthcare Barcelona, Spain | Pharma | Commercial | VIEW |
| 126. |  European Medicines BV Lelystad, Netherlands | CRO | Commercial | VIEW |
| 127. |  Evernorth Health Services St. Louis, USA | Digital Health | Commercial | VIEW |
| 128. |  Evolution Health Group, LLC Pearl River, New York, USA | CRO | Commercial | VIEW |
| 129. |  Exeltis Florham Park, USA (Global HQ in Madrid, Spain) | Biotech | Commercial | VIEW |
| 130. |  | CDMO | Commercial | VIEW |
| 131. |  FFF Enterprises, Inc. Temecula, USA | CDMO | Commercial | VIEW |
| 132. |  | Pharma | Commercial | VIEW |
| 133. |  Fidelity Investments Boston, USA | Pharma | Commercial | VIEW |
| 134. |  Flagship Pioneering Cambridge, USA | Biotech | Discovery | VIEW |
| 135. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 136. |  Forma Therapeutics Inc Watertown, USA | Biotech | Phase 3 | VIEW |
| 137. |  Fortrea Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 138. |  Freyr Solutions Princeton, New Jersey, USA | CRO | Commercial | VIEW |
| 139. |  Fujifilm Diosynth Biotechnologies Morrisville, North Carolina, USA | CDMO | Commercial | VIEW |
| 140. |  | Digital Health | Commercial | VIEW |
| 141. |  G&L Scientific Marlow, United Kingdom | CRO | Commercial | VIEW |
| 142. |  | Biotech | Phase 1|Phase 2|Commercial | VIEW |
| 143. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 144. |  | Digital Health | Commercial | VIEW |
| 145. |  George Mason University Fairfax, USA | Biotech | Phase 2 | VIEW |
| 146. |  Global Life Sciences Alliance Philadelphia, PA, USA | CRO | Commercial | VIEW |
| 147. |  GlobalData Plc London, United Kingdom | Digital Health | Commercial | VIEW |
| 148. |  Guangzhou Cellprotek Pharmaceutical Guangzhou, China | Biotech | Phase 3 (Planning) | VIEW |
| 149. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 150. |  Halozyme Therapeutics San Diego, USA | Biotech | Commercial | VIEW |
| 151. |  Hamad Bin Khalifa University (HBKU) Doha, Qatar | Biotech | Preclinical | VIEW |
| 152. |  Haymarket Media Group London, United Kingdom | Digital Health | Commercial | VIEW |
| 153. |  | Digital Health | Commercial | VIEW |
| 154. |  Heligenics Phoenix, Arizona, USA | Biotech | Discovery | VIEW |
| 155. |  Helix RA Mexico City, Mexico | CRO | Commercial | VIEW |
| 156. |  Hevolution Foundation Riyadh, Saudi Arabia | Biotech | Discovery | VIEW |
| 157. |  Holostem S.r.l. Modena, Italy | Biotech | Commercial | VIEW |
| 158. |  | Digital Health | Commercial | VIEW |
| 159. |  | MedTech | Commercial | VIEW |
| 160. |  Hong Kong University of Science and Technology (Guangzhou) Guangzhou, China | Biotech | Phase 2 | VIEW |
| 161. |  Hospital Israelita Albert Einstein São Paulo, Brazil | Diagnostics | Commercial | VIEW |
| 162. |  HungaroTrial CRO Budapest, Hungary | CRO | Commercial | VIEW |
| 163. |  Huron Consulting Group Chicago, USA | CRO | Commercial | VIEW |
| 164. |  Hyloris Pharmaceuticals SA Liège, Belgium | Biotech | Commercial | VIEW |
| 165. |  ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain | CRO | N/A (Service Provider) | VIEW |
| 166. |  IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary) | CRO | N/A - Service Provider | VIEW |
| 167. |  Idorsia Allschwil, Switzerland | Biotech | Commercial | VIEW |
| 168. |  Immorna Biotherapeutics Morrisville, USA | Biotech | Phase 2 | VIEW |
| 169. |  Incyte Wilmington, Delaware, USA | Biotech | Commercial | VIEW |
| 170. |  Initial Therapeutics South San Francisco, USA | Biotech | Discovery | VIEW |
| 171. |  | CRO | Commercial | VIEW |
| 172. |  Insmed Incorporated Bridgewater, New Jersey, USA | Biotech | Commercial | VIEW |
| 173. |  Institute for Bioengineering of Catalonia (IBEC) Barcelona, Spain | Biotech | Preclinical | VIEW |
| 174. |  Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU Munich Munich, Germany | CRO | Commercial | VIEW |
| 175. |  Intellia Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 176. |  Inttl Advocare New Delhi, India | CRO | Commercial | VIEW |
| 177. |  IntuitionLabs San Jose, California, USA | Digital Health | Commercial | VIEW |
| 178. |  Ipsen Boulogne-Billancourt, France | Pharma | Commercial | VIEW |
| 179. |  Ironwood Pharmaceuticals Boston, USA | Biotech | Commercial | VIEW |
| 180. |  Italfarmaco Group Milan, Italy | Pharma | Commercial | VIEW |
| 181. |  JW Pharmaceutical Gwacheon, South Korea | Pharma | Commercial | VIEW |
| 182. |  Jazz Pharmaceuticals Dublin, Ireland | Pharma | Phase 1 through Commercial | VIEW |
| 183. |  KMK Consulting Inc. Morristown, New Jersey, USA | CRO | Commercial | VIEW |
| 184. |  Kapadi Raleigh, North Carolina, USA | CRO | Commercial | VIEW |
| 185. |  Katrina Rogers Consulting LLC Spokane, Washington, USA | CRO | Commercial | VIEW |
| 186. |  Kedrion Biopharma Barga, Italy | Biotech | Commercial | VIEW |
| 187. |  Kinexum Harpers Ferry, USA | CRO | Commercial | VIEW |
| 188. |  Kiniksa Pharmaceuticals London, United Kingdom | Biotech | Commercial | VIEW |
| 189. |  Komtur Pharmaceuticals Freiburg, Germany | CRO | Commercial | VIEW |
| 190. |  KromaTiD, Inc. Longmont, USA | Biotech | Discovery | VIEW |
| 191. |  | Pharma | Commercial | VIEW |
| 192. |  Kyung Hee University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 193. |  Labcorp Burlington, North Carolina, USA | Diagnostics | Commercial | VIEW |
| 194. |  Laboratoires Servier Orléans, France | Pharma | Preclinical through Commercial | VIEW |
| 195. |  Laboratorios Bagó Buenos Aires, Argentina | Biotech | Commercial | VIEW |
| 196. |  Leoben Research Rome, Italy | CRO | Commercial | VIEW |
| 197. |  Lexbridge Co., Ltd. Sakai, Osaka, Japan | CRO | Commercial | VIEW |
| 198. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 199. |  Link Innovations Bengaluru, India | Digital Health | Commercial | VIEW |
| 200. |  | CDMO | Commercial | VIEW |
| 201. |  MARS Group Inc. Bloomington, Illinois, USA | CRO | Commercial | VIEW |
| 202. |  MRH Regulatory Sciences San Francisco, USA | CRO | Commercial | VIEW |
| 203. |  Macrogen Europe Amsterdam, Netherlands | CRO | Commercial | VIEW |
| 204. |  Medical University of Silesia Katowice, Poland | Diagnostics | Commercial | VIEW |
| 205. |  Medidata Solutions New York City, USA | Digital Health | - | VIEW |
| 206. |  Medison Pharma Petah Tikva, Israel | Biotech | Commercial | VIEW |
| 207. |  Menarini Stemline New York, USA | Biotech | Commercial | VIEW |
| 208. |  Mentor Technical Group Caguas, Puerto Rico | CRO | Commercial | VIEW |
| 209. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 210. |  Mersana Therapeutics Cambridge, USA | Biotech | Phase 1 | VIEW |
| 211. |  MetaQ Trials Tel Aviv, Israel | Digital Health | Commercial | VIEW |
| 212. |  Metagenomi Emeryville, USA | Biotech | Preclinical | VIEW |
| 213. |  | Biotech | Preclinical | VIEW |
| 214. |  Micron, Inc. Minato-ku, Tokyo, Japan (with Kobe operations history) | CRO | Clinical Development Support | VIEW |
| 215. |  Minovia Therapeutics Tirat Carmel, Israel | Biotech | Phase 2 | VIEW |
| 216. |  Mirum Pharmaceuticals Foster City, USA | Biotech | Commercial | VIEW |
| 217. |  | Biotech | Commercial | VIEW |
| 218. |  Mogam Institute for Biomedical Research Seoul, South Korea | Biotech | Discovery|Preclinical | VIEW |
| 219. |  Mubadala Bio Abu Dhabi, United Arab Emirates | CDMO | Commercial (Manufacturing & Distribution) | VIEW |
| 220. |  Mucpharm Kogarah, Sydney, New South Wales 2217, Australia | Biotech | Phase 2 | VIEW |
| 221. |  | Biotech | Commercial | VIEW |
| 222. |  | CRO | Commercial | VIEW |
| 223. |  NPDK Bioconsulting San Diego, California | CRO | Commercial | VIEW |
| 224. |  | Biotech | Preclinical | VIEW |
| 225. |  National Resilience, Inc. La Jolla, California, USA | CDMO | Commercial | VIEW |
| 226. |  Neurocrine Biosciences San Diego, USA | Biotech | Commercial | VIEW |
| 227. |  Neurogene Inc. New York, NY | Biotech | Phase 2 | VIEW |
| 228. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 229. |  Novo Nordisk Bagsværd, Denmark | Pharma | Commercial | VIEW |
| 230. |  | CRO | Discovery through Phase IV | VIEW |
| 231. |  Null Hypothesis Hangzhou, China | Digital Health | Commercial | VIEW |
| 232. |  Oceanus Plus Beijing, China | Digital Health | Commercial | VIEW |
| 233. |  On/Off Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 234. |  Oncotelic Therapeutics Agoura Hills, California, USA | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 235. |  Optum Eden Prairie, Minnesota, USA | Digital Health | Commercial | VIEW |
| 236. |  Oracle Corporation Austin, Texas, USA | Pharma | Commercial | VIEW |
| 237. |  Orchard Therapeutics London, United Kingdom | Biotech | Commercial | VIEW |
| 238. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 239. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 240. |  PBS Regulatory Consulting Bridgewater, New Jersey, USA | CRO | Commercial | VIEW |
| 241. |  PPD (Pharmaceutical Product Development) Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 242. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 243. |  Partex NV Eschborn, Germany | Biotech | Phase 2 | VIEW |
| 244. |  Pfizer New York, United States | Pharma | Phase 1-3 and pending approval | VIEW |
| 245. |  PharmaLex Mannheim, Germany (Hans-Thoma-Straße 22, 68163 Mannheim) / Bad Homburg, Germany | CRO | N/A - Service Provider (not drug developer) | VIEW |
| 246. |  PharmaLex (now Cencora PharmaLex) Multiple global headquarters; main offices in Switzerland and US | CRO | Consulting/Support across all stages - Discovery through Phase 4 | VIEW |
| 247. |  Pharvaris N.V. Leiden, Netherlands / Zug, Switzerland | Biotech | Phase 3 | VIEW |
| 248. |  PicnicHealth San Francisco, USA | Digital Health | Commercial | VIEW |
| 249. |  Pierre Fabre Group Castres, France | Pharma | Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 250. |  Piramal Pharma Limited Mumbai, India | CDMO | Commercial Manufacturing (primarily services other companies' pipelines) | VIEW |
| 251. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 252. |  Precigen Germantown, Maryland, USA | Biotech | Commercial | VIEW |
| 253. |  Precision Medicine Group Bethesda, USA | CRO | Commercial | VIEW |
| 254. |  Precision for Medicine Bethesda, Maryland, USA | CRO | Commercial | VIEW |
| 255. |  Premier Research Morrisville, North Carolina, USA | CRO | N/A (Service Provider) | VIEW |
| 256. |  Pyramid Laboratories, Inc. Costa Mesa, USA | CDMO | Commercial | VIEW |
| 257. |  Qilu Pharmaceutical 8888 Lvyou Road, High-tech Zone, Jinan, China | Pharma | Discovery through Commercial | VIEW |
| 258. |  RWS Group Chalfont St Peter, United Kingdom | CRO | Commercial | VIEW |
| 259. |  Rancho BioSciences San Diego, USA | CRO | - | VIEW |
| 260. |  | CRO | Commercial | VIEW |
| 261. |  Recordati S.p.A. Milan, Italy | Pharma | Commercial | VIEW |
| 262. |  Recursion Pharmaceuticals Salt Lake City, Utah, USA | Biotech | Phase 1-2 | VIEW |
| 263. |  | Diagnostics | Commercial | VIEW |
| 264. |  Rho Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 265. |  | Biotech | Phase 2 | VIEW |
| 266. |  | CRO | Commercial | VIEW |
| 267. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 268. |  Roche Holding AG (via businesspartner.roche.com portal) Basel, Switzerland | Pharma | Phase 1 through Commercial | VIEW |
| 269. |  Saama Technologies Campbell, USA | Digital Health | Commercial | VIEW |
| 270. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 271. |  Saol Therapeutics Roswell, USA | Biotech | Phase 3 | VIEW |
| 272. |  Sarepta Therapeutics Cambridge, USA | Biotech | Commercial | VIEW |
| 273. |  Sartorius Göttingen, Germany | CDMO | Commercial | VIEW |
| 274. |  Scenic Biotech Amsterdam, The Netherlands | Biotech | Preclinical to IND-enabling | VIEW |
| 275. |  Shionogi & Co., Ltd. Osaka, Japan | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 276. |  Simtra BioPharma Solutions Bloomington, Indiana, USA | CDMO | Commercial | VIEW |
| 277. |  Spot Biosystems Palo Alto, USA | Biotech | Preclinical | VIEW |
| 278. |  StemSynergy Therapeutics Miami, Florida, USA | Biotech | Preclinical and IND-enabling | VIEW |
| 279. |  Stoke Therapeutics Bedford, USA (Moving to Waltham, MA in late 2026) | Biotech | Phase 3 | VIEW |
| 280. |  Sumitomo Pharma America, Inc. Marlborough, USA | Pharma | Commercial | VIEW |
| 281. |  Svar Life Science Malmö, Sweden | Diagnostics | Commercial | VIEW |
| 282. |  Syneos Health Morrisville, North Carolina, USA | CRO | Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial) | VIEW |
| 283. |  Syner-G BioPharma Group Framingham, Massachusetts, USA | CRO | Private Equity Backed | VIEW |
| 284. |  Synexa Life Sciences Leiden, Netherlands | CRO | Commercial | VIEW |
| 285. |  Syngene International Bengaluru, India | CRO | Commercial | VIEW |
| 286. |  TFS HealthScience Lund, Sweden | CRO | Commercial | VIEW |
| 287. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 288. |  Tanabe Pharma Corporation Osaka, Japan | Pharma | Commercial | VIEW |
| 289. |  Tata Consultancy Services Mumbai, India | CRO | Commercial | VIEW |
| 290. |  Technology Resources, Inc. West Chester, Pennsylvania, USA | CRO | Commercial | VIEW |
| 291. |  TerSera Therapeutics Deerfield, IL, USA | Biotech | Commercial | VIEW |
| 292. |  The ConfluenceElite Group, LLC Greater Philadelphia Area, USA | CRO | Commercial | VIEW |
| 293. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 294. |  | CRO | Commercial | VIEW |
| 295. |  Tonix Pharmaceuticals Holding Corp. Chatham, New Jersey, USA | Biotech | Commercial | VIEW |
| 296. |  Travalcon Scarborough, Canada | Digital Health | Commercial | VIEW |
| 297. |  TrialBlaze Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 298. |  Trinity Life Sciences Waltham, USA | CRO | Commercial | VIEW |
| 299. |  | Pharma | Commercial | VIEW |
| 300. |  UK Biobank Stockport, United Kingdom | Diagnostics | Commercial | VIEW |
| 301. |  Ultragenyx Pharmaceutical Inc. Novato, USA | Biotech | Commercial | VIEW |
| 302. |  University of British Columbia Vancouver, Canada | Biotech | Discovery | VIEW |
| 303. |  University of California, Berkeley Berkeley, USA | Biotech | Discovery | VIEW |
| 304. |  University of Cincinnati Cincinnati, USA | Biotech | Commercial | VIEW |
| 305. |  University of Colorado Boulder Boulder, USA | Biotech | Discovery | VIEW |
| 306. |  University of Essex Colchester, United Kingdom | Biotech | Discovery | VIEW |
| 307. |  University of Wisconsin–Madison Madison, USA | Biotech | Commercial | VIEW |
| 308. |  Value Genome LLC Exton, Pennsylvania, USA | CRO | Commercial | VIEW |
| 309. |  VitalStage Ventures San Francisco, USA | Digital Health | Commercial | VIEW |
| 310. |  WEP Clinical Morrisville, USA | CRO | Commercial | VIEW |
| 311. |  Weatherden London, United Kingdom | CRO | Phase 2 | VIEW |
| 312. |  Whyze Health Dublin, Ireland | Digital Health | Commercial | VIEW |
| 313. |  WriteSource Medical Pty Ltd North Sydney, Australia | CRO | Commercial | VIEW |
| 314. |  WuXi AppTec Shanghai, China | CRO | Commercial | VIEW |
| 315. |  X4 Pharmaceuticals Boston, USA | Biotech | Commercial | VIEW |
| 316. |  Xencor, Inc. Pasadena, California, USA | Biotech | Phase 1/2 | VIEW |
| 317. |  | CRO | Commercial | VIEW |
| 318. |  Ziphius Vaccines Ghent, Belgium | Biotech | Preclinical | VIEW |
| 319. |  Zydus Lifesciences Limited Ahmedabad, India | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 320. |  | CRO | Commercial | VIEW |
| 321. |  epiVeris Steamboat Springs, Colorado | Digital Health | - | VIEW |
| 322. |  | Digital Health | Commercial | VIEW |